NORML

APRIL 30, 2020

The call for comments, posted on April 17 at regulations.gov here , states: “Interested persons or organizations are invited to participate by submitting written views, recommendations, and data related to perspectives on and experiences with pain and pain management. percent in 2016).”

Chronic Pain 344

Chronic Pain Clinical Trials Data Patients 344

NORML

NOVEMBER 25, 2019

Patients suffering from persistent pain conditions who frequently use cannabis are far less likely to use non-prescription opioids, according to longitudinal data published in the journal PLOS One. Additional information is available from the NORML fact-sheet , ‘Relationship Between Marijuana and Opioids.’

Chronic Pain 280

Chronic Pain Patients Therapy Data 280

Cannabis Law Report

DECEMBER 11, 2021

The UK’s first and highest-rated medical cannabis clinic, Sapphire Medical Clinics , has today announced that it is reducing the cost of its consultations and appointments for patients enrolled through the Sapphire Access Scheme. The Sapphire Access Scheme will be open to an additional 2,000 patients in the UK.

Access 52

Access Patients Chronic Pain Treatment 52

United Patients Group

JUNE 8, 2023

A high-quality patient experience is paramount in any healthcare setting. Satisfied patients are more likely to trust their healthcare providers. It encourages patients to ask questions, provide accurate information, and participate in shared decision-making, leading to better treatment adherence and overall care quality.

Patients 52

Patients Data Collective Environment 52

Cannabis Law Report

JULY 2, 2022

reported a data breach stemming from a misconfigured web application that caused personal information to be accessible on the company’s website. On June 17, 2022, Silverstreak filed an official notice of the breach and sent out data breach letters to all affected parties. Console and Associates, P.C. Richard Console, Jr.

Data 52

Data Access Topical Cannabis 52

Cannabis Law Report

AUGUST 23, 2022

A panel of Commonwealth Court judges has ordered the Wolf administration to reveal how many medical marijuana patients have received approval from a doctor to use cannabis for opioid addiction treatment. For more than a year, the Department of Health has fought to keep that information secret.

Data 52

Data Treatment Patients Chronic Pain 52

Cannabis Law Report

JANUARY 20, 2023

When Oregon voters passed Measure 109 in 2020, to create a legal framework for access to psilocybin services, the ballot initiative explicitly prevented the government from collecting that sensitive personal information without consent. […]

Data 52

Data Patients Legislation Collective 52

Veriheal

AUGUST 7, 2022

New data published in the Journal of Cannabis Research claims that almost one in two authorized medical cannabis patients in Canada managed to either completely stop or reduce their intake of controlled substances, such as alcohol and opioids , by using cannabis. As of 2020, the market was worth CAD $2.6 billion (USD $2 billion).

Consumption 109

Consumption Patients Research and Development Data 109

The Cannigma

JANUARY 16, 2021

Listen & Subscribe: Finding the right cannabis product can be a daunting task for anyone, let alone a new medical patient without any guidance. “That’s where we’re trying to fill that need and plug that gap and help individuals inform their purchase decision.” Edited and mixed by Michael Schaeffer Omer-Man.

Data 100

Data Research and Development Patients Strains 100

Veriheal

MAY 26, 2022

Patients around the world are in need of natural, alternative medical solutions, and Realm of Caring (RoC) is on a mission to serve them. RoC also works to increase patients’ access to medical cannabis by helping U.S. To date, Veriheal’s global team has helped hundreds of thousands of patients gain access to medical cannabis.

Advocacy 98

Advocacy Patients Clinical Trials Education 98

NORML

JUNE 10, 2020

The agency’s call for comments, initially posted on April 17 at regulations.gov here , states: “Interested persons or organizations are invited to participate by submitting written views, recommendations, and data related to perspectives on and experiences with pain and pain management. percent in 2016).”

Chronic Pain 243

Chronic Pain Therapy Patients Topical 243

Veriheal

DECEMBER 14, 2021

An Analysis of Nationwide EVALI Data. The report explained that recreational legalization “could have dampened market penetration of tainted marijuana concentrates by reducing consumption of informally-sourced marijuana products more generally.”

Data 98

Data Vaping Legalization Consumption 98

CannaMD

MARCH 4, 2020

Releaf is a free mobile app to help patients track, learn from, and improve their use of medical cannabis. The data that is collected in Releaf App is used for multiple research studies and helps physicians identify what products patients are finding most effective. Patients can learn more by visiting ReleafApp.com.

Patients 79

Patients Data Collective Treatment 79

MMJ Recs

MAY 3, 2024

With its program in full swing, thousands of patients across the state are benefiting from access to this alternative form of treatment. From chronic pain to PTSD, patients with qualifying medical conditions have found solace in medical marijuana where traditional treatments may have fallen short.

Marijuana 52

Marijuana Treatment Compliance Compliance 52

SpeedWeed

MARCH 14, 2021

Big data and technology have become critical to a wide variety of industries in recent years, and the cannabis industry is no exception. Through advanced data collection and the application of sophisticated algorithms, usable data is now available to help marijuana businesses: Predict trends. Met consumer demands. Reduce costs.

Data 52

Data Research and Development Marijuana Collective 52

Americans for Safe Access

MARCH 24, 2020

With everything happening in the news lately, we want to present some scientific data to help medical cannabis patients and adult-use consumers make informed decisions in regard to cannabis products available, product safety, and personal health.

Cannabinoids 241

Cannabinoids Data Safety Patients 241

United Patients Group

JANUARY 4, 2024

As we move forward into 2024 and beyond, the sector offers diverse paths beyond direct patient care. The growth stems from rising healthcare demand, facility expansion, and the imperative for efficient administration to maintain quality patient care. Adverse drug events (ADEs) affect approximately 7 per 100 hospitalized patients.

Research and Development 52

Research and Development Patients Data Policy 52

Cannabis Law Report

FEBRUARY 10, 2023

The case, which was […]

Data 52

Data Access Patients Cannabis 52

Cannabis Law Report

JANUARY 23, 2020

Click on image to access THSuite website. Report: Cannabis Users’ Sensitive Data Exposed in Data Breach. Led by internet privacy researchers Noam Rotem and Ran Locar, vpnMentor’s research team discovered a data breach in THSuite, a point-of-sale system in the cannabis industry. THSuite Company Profile.

Data 59

Data Dispensary Patients Medicine 59

TheAnswerPage

JANUARY 11, 2022

Are you able to answer your patients’ medical marijuana questions? In fact, from pediatricians to geriatricians, I cannot think of any medical practitioner that does not need to be well informed about the endocannabinoid system and cannabis-based therapeutics. million medical marijuana patients nationwide.

Patients 98

Patients Education Marijuana Therapy 98

The Cannigma

FEBRUARY 2, 2021

In a new survey of German patients with Parkinson’s disease, 8% of patients reported using cannabis products. However, the survey also revealed that, among the Parkinson’s disease patients , there was a noticeable knowledge gap concerning the different methods of consumption available and the individual effects of THC and CBD.

Patients 87

Patients Clinical Trials Research and Development Treatment 87

Illinois News Joint

MAY 16, 2023

Metrc stated, “Seamless data tracking in Metrc helps operators optimize inventory control, accurately report sales data, and improve cultivation management. To qualify and receive a medical patient card at a discounted rate, visit here. For more Illinois cannabis industry news, visit here.

Seed-To-Sale 70

Seed-To-Sale Supply Chain Data Compliance 70

Cannabis Law Report

AUGUST 14, 2019

Let’s take a closer look at five key ways big data and technology are directly impacting the industry. Big Data Streamlines the Marijuana Regulatory Process and Helps Close the Scientific Research Gap. Therefore, the growing marijuana market lacks the clinical data needed to help marijuana businesses create new and better products.

Data 45

Data Research and Development Marijuana Collective 45

MMJ Recs

JUNE 15, 2022

The best pain management physicians collaborate with the patient to develop a treatment regimen that works best for them as an individual. They offer top-rated doctors and pain relief specialists that work with each patient to develop a treatment plan tailored to their specific needs. Unique Pain Medicine.

Patients 52

Patients Treatment Clinical Trials Therapy 52

Cannabis Law Report

JUNE 1, 2021

The initial shipment is designated to be used by the Clinic in a pilot run in preparation for the previously announced study , based out of the United Kingdom, on the safety and efficacy of cannabis and hemp for the treatment of patients suffering from chronic pain. billion, servicing nearly 340,000 active patients. RYAH Group, Inc.

Clinical Trials 89

Clinical Trials Chronic Pain Data Research and Development 89

Cannabis Chronicles

MAY 22, 2019

SPOKANE — Researchers at Washington State University are teaming up with the Puyallup Tribe of Indians in an effort to chart the tribe’s outcomes prescribing medicinal marijuana to patients. This partnership with WSU and Qwibil will help us research the safety and efficacy of cannabis as medicine for our patients’ use.”.

Medicine 140

Medicine Research and Development Data Collective 140

Cannabis Law Report

JUNE 23, 2021

Medicann is a premier cannabis-specialized clinic, providing patients with access to local specialist doctors and pharmacists that have experience prescribing cannabis-based medication. billion, servicing nearly 340,000 active patients. In 2019, the island’s economy grew by 2.1% in real terms to £4.97 to reach 3.2

Programs 100

Programs Data Events Collective 100

Veriheal

MAY 30, 2023

A new 2023 study published in BMJ Supportive & Palliative Care suggests that cannabis could be the answer millions of cancer patients have been looking for. of patients experience pain after curative treatment, while 66.4% of patients with advanced or metastatic cancer suffer from pain. Interestingly, 72.5%

Medicine 98

Medicine Treatment Patients Data 98

Cannabis Law Report

AUGUST 23, 2021

The TGA recently released a new medical cannabis dashboard detailing a variety of information on both SAS-A and SAS-B approvals. They announced that they’re ‘committed to ongoing transparency and will release additional datasets in the future’, such as data on Authorised Prescriber applications and the concentrations of active ingredients.

Chronic Pain 105

Chronic Pain Concentrates Conditions Data 105

NORML

MAY 21, 2019

The administration of oral CBD reduces cue-induced cravings and anxiety in subjects with a history of heroin use, according to clinical data published in The American Journal of Psychiatry. ” In observational models , patients with legal access to cannabis typically reduce or eliminate their use of opioids.

Clinical Trials 185

Clinical Trials CBD History Data 185

The Joint Blog

MAY 5, 2020

PatientsAccording to a new study, access to cannabis reduces pain patients’ perceived demand for opioids. For the study researchers from John Hopkins School of Medicine examined whether or not cannabis availability would hypothetically influence pain patients’ demand for prescription opioids.

Access 49

Access Consumption Marijuana Medicine 49

MMJ Recs

NOVEMBER 17, 2023

This article explores the profound impact of MMJ on Maryland communities, shedding light on the medical marijuana benefits experienced by patients and the positive effects it has had on the state’s communities. It has the potential to reduce opioid dependence and addiction, leading to safer and healthier communities.

Chronic Pain 98

Chronic Pain Therapy Research and Development Treatment 98

Cannabis Law Report

JULY 13, 2021

The deal with LYPHE Group means that thousands of patients will be the first in Europe to have access to pain relief delivered in a metered dose via Kanabo’s VapePod. Kanabo’s medical line aims to enable patients to move away from the harmful habit of smoking medical cannabis flowers.

Extraction 105

Extraction Vaping Medicine Patients 105

Veriheal

DECEMBER 14, 2023

Study Results The study, published in CNS Drugs, tested 40 participants on their ability to complete neurological-based tests on pattern recognition, multitasking, reaction time, information processing, and working memory.

Chronic Pain 120

Chronic Pain Consumption Cannabis Marijuana 120

Cannabis Law Report

JULY 21, 2021

You can access the report here. Data Snapshot: Cannabis Consumer Spending and Trends: James Ahrendt , Business Intelligence Architect, Akerna. Using connected data and information to propel the cannabis industry forward, Akerna empowers businesses, governments, patients, and consumers to make smart decisions.

Supply Chain 105

Supply Chain Seed-To-Sale Data Research and Development 105

Cannabis Law Report

AUGUST 24, 2022

New research from the University of Sydney’s Lambert Initiative finds most Australians are still medicating with illicit cannabis, although numbers accessing prescription products have risen dramatically. These include safer routes of administration, greater certainty of access, and better communication between patients and doctors.

Medicine 52

Medicine Legalization Chronic Pain Access 52

Cannabis Law Report

JULY 22, 2022

As the only track-and-trace company to have successfully taken over a government contract from another vendor, Metrc will replace the State’s current partner and implement its robust track-and-trace platform to help facilitate the Rhode Island Medical Cannabis Program’s data collection and regulatory oversight. and now Rhode Island.

Data 52

Data Programs Access Compliance 52